Kirsty (Insulin Aspart)

Insulin Aspart is a rapid‑acting insulin analog that lowers blood glucose by facilitating cellular uptake. It is indicated for the following conditions:

• Type 1 diabetes mellitus: provides mealtime glucose control and reduces post‑prandial spikes.
• Type 2 diabetes mellitus: used when oral agents are insufficient to achieve target glycaemia.
• Gestational diabetes mellitus: helps maintain maternal glucose levels within recommended ranges during pregnancy.

• Insulin Aspart binds to insulin receptors on muscle and adipose tissue, activating the receptor’s intrinsic tyrosine kinase activity. This triggers intracellular signaling cascades that promote translocation of GLUT‑4 transporters to the cell membrane, enhancing glucose uptake, and suppresses hepatic glucose production, thereby lowering blood glucose levels.

Insulin Aspart may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

• Hypoglycaemia: low blood sugar episodes, especially if meals are missed.
• Injection site reactions: redness, swelling, or itching at the injection site.
• Lipodystrophy: localized changes in subcutaneous fat with repeated injections.
• Nausea or abdominal discomfort.
• Weight gain: due to improved glucose utilization.

Serious or Rare Side Effects

• Severe hypoglycaemia leading to seizures or loss of consciousness.
• Allergic reactions: rash, urticaria, or anaphylaxis.
• Hypokalemia: low potassium levels.
• Edema: fluid retention, particularly in the lower extremities.
• Hypoglycaemia unawareness: diminished ability to recognize low glucose symptoms.

When using Insulin Aspart, several safety considerations are important.

• Blood glucose monitoring: check levels frequently to adjust dose as needed.
• Dose adjustments: modify insulin when dietary intake, activity, or illness changes.
• Hypoglycaemia unawareness: avoid in patients who cannot recognize low glucose symptoms.
• Renal or hepatic impairment: use with caution and consider dose reduction.
• Pregnancy and lactation: safety category unknown; weigh benefits against potential risks.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin Aspart can interact with other medicines, affecting glucose control.

Major Interactions (Avoid)

• Sulfonylureas: additive risk of severe hypoglycaemia.
• Beta‑blockers: may mask hypoglycaemia symptoms.
• Glucocorticoids: can increase blood glucose, reducing insulin effectiveness.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors: may potentiate insulin’s glucose‑lowering effect.

• Thiazide diuretics: can raise blood glucose levels.
• Alcohol: may cause unpredictable hypoglycaemia, especially with missed meals.